학술논문

In vitro/in vivo performance of different complexes of itraconazole used in the treatment of vaginal candidiasis
Document Type
article
Source
Brazilian Journal of Pharmaceutical Sciences. December 2012 48(4)
Subject
Itraconazole/complexes
Itraconazole/evaluation
Itraconazole/complexes
Itraconazole/in vitro
Itraconazole/in vivo performance
Vaginal candidiasis/treatment
Drugs/solubility
Drugs/formulation
Language
English
ISSN
1984-8250
Abstract
A large majority of new chemical entities and many existing drug molecules exhibit poor aqueous solubility, which may limit their potential use in developing drug formulations, with optimum bioavailability. One of the approaches to improve the solubility of a poorly water soluble drug and eventually its bioavailability is complexation with agents like humic acid (HA), fulvic acid (FA), β-cyclodextrin (β-CD), 2-hydroxypropyl-β-cyclodextrin (HP-β-CD) and caffeine (Caff). The current work emphasized at employing these agents to prepare different complexes and their in vitro/in vivo assessment. All the complexes evaluated for their complexation efficiency and authenticated by molecular modeling; conformational analysis, differential scanning calorimetry (DSC), X-ray diffraction (XRD), nuclear magnetic resonance (NMR) and mass spectroscopy. Furthermore, the complexes were assessed in an in vivo, rat vaginal model for their efficacy in treatment of vaginal candidiasis. Amongst the five tested complexes, fulvic acid-itraconazole complex yielded better solubility as well as in vivo efficacy and therefore may further be explored for developing a commercial formulation for treating vaginal candidiasis.